• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchPasithea Therapeutics
    Picture of Pasithea Therapeutics logo

    KTTA — Pasithea Therapeutics News Story

    $0.400.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    • Market Cap
      $13.53m
    • Enterprise Value
      -$32.13m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • KTTA Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    KTTA Dividends
    All News

    NASDAQ RESUMED AT 09:37 AM

    Picture of Pasithea Therapeutics logoPasithea Therapeutics
    28/11/2025 14:37
    NASDAQ RESUMED  KTTA.O  AT 09:37 AM
    

    Recent news on Pasithea Therapeutics

    See all news
    • Pasithea Therapeutics Corp reports results for the quarter ended June 30 - Earnings Summary

      14/08/2026 22:14
    • Pasithea Therapeutics Corp expected to post a loss of 16 cents a share - Earnings Preview

      10/08/2026 12:46
    • Brief: Pasithea Therapeutics Announces Positive Interim Phase 1 Advanced Cancer Study Data

      30/06/2026 12:06
    • Brief: Pasithea Therapeutics Announces Closing Of $60 Million Public Offering Of Common Stock

      02/12/2025 12:59
    • Pasithea Therapeutics jumps after $60 million public offering announcement

      28/11/2025 16:36

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.